제품 > 항체 > 인산화 특이적 항체

Phospho-JAK2-Y1008 Rabbit pAb (AP0772)

Datasheet

Tested applications:WBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibitionReactivity:Human

ABclonal:Western blot - Phospho-JAK2-Y1008 Rabbit pAb (AP0772)

Western blot analysis of lysates from Jurkat cells, using Phospho-JAK2-Y1008 Rabbit pAb (AP0772) at 1:2000 dilution. Jurkat cells were treated by Pervanadate (1mM) for 30 minutes.
Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
Lysates/proteins: 25μg per lane.
Blocking buffer: 3% BSA.
Detection: ECL Basic Kit (RM00020).
Exposure time: 1s.

Overview

Product namePhospho-JAK2-Y1008 Rabbit pAb
Catalog No.AP0772
Host speciesRabbit
Purification methodAffinity purification
IsotypeIgG
This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
ImmunogenA synthetic phosphorylated peptide around Y1008 of human Phospho-JAK2-Y1008 (NP_004963.1).
SequenceEYYKV
Gene ID
Swiss Prot
SynonymsJTK10; Phospho-JAK2-Y1008
Calculated MW131kDa
Observed MW120kDa
ReactivityHuman
Tested applicationsWBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibition
Recommended dilution
  • WB 1:500 - 1:2000
Storage bufferStore at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.01% thimerosal, 50% glycerol, pH7.3.
Key applicationWestern blotting    
Positive samplesJurkat treated by Pervanadate
Cellular locationCytoplasm, Endomembrane system, Nucleus, Peripheral membrane protein
ABclonal:Western blot - Phospho-JAK2-Y1008 Rabbit pAb (AP0772)}

Western blot - Phospho-JAK2-Y1008 Rabbit pAb (AP0772)

Western blot analysis of lysates from Jurkat cells, using Phospho-JAK2-Y1008 Rabbit pAb (AP0772) at 1:2000 dilution. Jurkat cells were treated by Pervanadate (1mM) for 30 minutes.
Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
Lysates/proteins: 25μg per lane.
Blocking buffer: 3% BSA.
Detection: ECL Basic Kit (RM00020).
Exposure time: 1s.

* For research use only. Not for therapeutic or diagnostic purposes.

항체 (5)

Secondary Antibodies (26)